Evaluation of adsorption selectivity dextran sulfate bound cellulose beads for the removal of anti-DNA antibodies

Therapeutic Apheresis

Volumn 3, Issue 1, 1999, Pages 75-80

  Hidaka, Toshihiko ^a   Suzuki, Kimihiro ^a   Matsuki, Yasunori ^a   Takamizawa Matsumoto, Mitsuyo ^a   Kataharada, Kouji ^a   Ishizuka, Toshiaki ^a   Kawakami, Makoto ^a   Nakamura, Haruo ^a   Yabuki, Tetsuro ^b   Kutsuki, Hidetoshi ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KANEKA CORPORATION   (Japan)

Author keywords

Antinuclear antibody; Blood chemical components; Coagulation factors; Dextran sulfate cellulose columns; Hormones

Indexed keywords

ANTINUCLEAR ANTIBODY; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; CELLULOSE; DEXTRAN SULFATE; DNA ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY;

ADSORPTION; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; HUMAN; MAJOR CLINICAL STUDY; POLYMYOSITIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADSORPTION; AUTOANTIBODIES; DEXTRAN SULFATE; DNA; HUMANS; IMMUNOSORBENT TECHNIQUES;

EID: 6544276587     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.1999.00110.x     Document Type: Article

References (28)

1. Kinoshita M, Aotsuka S, Funahashi T, Tani T, Yokohari R. Selective removal of anti-double stranded DNA antibodies by immunoadsorption with dextran sulphate in a patient with systemic lupus erythematosus. Ann Rheum Dis 1989;48: 856-60.
2. Schneider M, Berning T, Waldendorf M, Glaser J, Gerlach U. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus. J Rheumatol 1990;17:900-7.
3. Suzuki K, Hara M, Ishizuka T, Hirose T, Harigai M, Kitani A, Kawagoe M, Nakamura H. Continuous anti-ds DNA antibody apheresis in systemic lupus erythematosus. Lancet 1990; 336:753-4.
4. Hidaka T, Harigai M, Suzuki K, Ishizuka T, Hara M, Kawagoe M, Nakamura H. Remission of hypersensitivity vasculitis following immunoadsorption for removal of immune complexes. Ther Plasmapheresis 1991;IX:398-402.
5. Suzuki K, Mimori T, Matsuki Y, Hidaka T, Kawaguchi Y, Ishizuka T, Kawakami M, Nakamura H. Successful treatment of polymyositis immunoadsorption in a patient with polymyositis-systemic sclerosis overlap. J Natl Def Med Coll 1993;18: 329-34.
6. Takamori M, Okumura S, Ide Y. A synthetic peptide, Torpedo californica a 183-200 of the acetylcholine receptor as a tool for immunoadsorption via plasma perfusion in myasthenia gravis. Artif Organs Today 1991;1:53-60.
7. Suzuki K, Hara M, Harigai M, Ishizuka T, Hirose T, Matsuki Y, Kawaguchi Y, Kitani A, Kawagoe M, Nakamura H. Continuous removal of anti-DNA antibody, using a new extracorporeal immunoadsorption system, in patients with systemic erythematosus. Arthritis Rheum 1991;34:1546-52.
8. Hashimoto H, Tsuda M, Kanai Y, Kobayashi S, Shinoura H, Yokohari R, Kinoshita M, Aotsuka S, Yamada H, Takahashi K, Yoshinoya S, Miyamoto T. Selective removal of anti-DNA and anticardiolipin antibodies by adsorbent plasmapheresis using dextran sulfate columns in patients with systemic lupus erythematosus. J Rheumatol 1991;18:545-51.
9. Matsuki Y, Suzuki K, Kawakami M, Ishizuka T, Kawaguchi Y, Hidaka T, Nakamura H. High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns. J Clin Apheresis 1996;11:30-5.
10. Faaber P, Rijke TPM, van de Putte LBA, Capel PJA, Berden JHM. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. J Clin Invest 1986;77:1824-30.
11. Yokoyama S, Hayashi R, Kikkawa T, Tani N, Takada S, Hatanaka K, Yamamoto A. Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis: Characterization and experimental use in hypercholesterolemic rabbits. Arteriosclerosis 1984;4:276-82.
12. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985;5:613-22.
13. Agishi T, Wood W, Gordon B. LDL apheresis using the Liposorber® LA-15 system in coronary and peripheral vascular disease associated with severe hypercholesterolemia. Curr Ther Res 1994;56:879-904.
14. Maddison PJ, Mogavero H, Reichlin M. Antibodies to nuclear ribonucleoprotein. J Rheumatol 1978;5:407-11.
15. Hedgpeth MT, Boulware DW. Interstitial pneumonitis in antinuclear antibody-negative systemic lupus erythematosus: A new clinical manifestation and possible association with antiRo (SS-A) antibodies. Arthritis Rheum 1988;31:545-8.
16. Wasichek CA, Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies in Ro versus patients without antibodies to Ro and La. J Clin Invest 1982;69:835-43.
17. Alexander EL, Arnett FC, Provost TT, Stevens MB. Sjögren's syndrome-association of anti-Ro (SSA) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 1983;98:155-9.
18. Scott JS, Maddison PJ, Taylor PJ, Escher E, Scott O, Skinner RP. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983;39: 209-12.
19. Takeda Y, Wang GS, Wang RJ, Anderson SK, Petterson I, Amaki S, Sharp GC. Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin Immunol Immunopathol 1989;50:213-30.
20. Reichlin M, van Venrooij WJ. Autoantibodies to the URNP particles: Relationship to clinical diagnosis and nephritis. Clin Exp Immunol 1991;83:286-90.
21. Catoggio LJ, Bernstein RM, Black CM, Hughes GR, Maddison PJ. Serological markers in progressive systemic sclerosis: Clinical correlations. Ann Rheum Dis 1983;42:23-7.
22. Suzuki N, Otuka I, Harada T, Mizushima Y, Sakane T. Preferential adsorption of cationic anti-DNA antibodies with immobilized polyanionic compounds, dextran sulfate. Autoimmunity 1994;19:105-12.
23. Kojima S, Harada-Shiba M, Toyota Y, Kimura G, Tsushima M, Kuramochi M, Sakata T, Uchida K, Yamamoto A, Omae T. Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis. Int J Artif Organs 1992;15:185-90.
24. Kling E, Bieg S, Boehme M, Scherbaum WA. Circulating intercellular adhesion molecule 1 as a new activity marker in patients with systemic lupus erythematosus. Clin Invest 1993; 71:299-304.
25. Carson CW, Beall LD, Hunder GG, Johnson CM, Newman W. Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. J Rheumatol 1993;20: 809-14.
26. Janssen BA, Luqmani RA, Gordon C, Hemingway IH, Bacon PA, Gearing AJ, Emery P. Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheumatol 1994;33:1112-6.
27. Sampietro T, Tuoni M, Ferdeghini M, Ciardi A, Marraccini P, Prontera C, Sassi G, Taddei M, Bionda A. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation 1997;96:1381-5.
28. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemia humans. Circulation 1997;95:76-82.